Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Equivalence of Linaclotide Formulations in Chronic Idiopathic Constipation
NCT04804267Phase 3Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in chronic idiopathic constipation (CIC), sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
linaclotide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT04804267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804267.